128 related articles for article (PubMed ID: 20456034)
61. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
[No Abstract] [Full Text] [Related]
62. Ursodeoxycholic acid in primary sclerosing cholangitis.
Triantos CK; Koukias N; Nikolopoulou V; Burroughs AK
Aliment Pharmacol Ther; 2012 Mar; 35(5):622-3. PubMed ID: 22300127
[No Abstract] [Full Text] [Related]
63. Cholestatic liver disease in long-term infantile nephropathic cystinosis.
Cornelis T; Claes K; Gillard P; Nijs E; Roskams T; Lombaerts R; Nevens F; Cassiman D
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e428-31. PubMed ID: 18466290
[TBL] [Abstract][Full Text] [Related]
64. Ursodeoxycholic acid for the treatment of cholestatic diseases.
Poupon RE; Poupon R
Prog Liver Dis; 1992; 10():219-38. PubMed ID: 1296231
[No Abstract] [Full Text] [Related]
65. [Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
Parés A; Rodés J
Gastroenterol Hepatol; 1996 Feb; 19(2):58-67. PubMed ID: 8616682
[No Abstract] [Full Text] [Related]
66. Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis.
Santander C; Moreno-Otero R
Aliment Pharmacol Ther; 2012 Apr; 35(7):846; discussion 847. PubMed ID: 22404405
[No Abstract] [Full Text] [Related]
67. [Ursodeoxycholic acid: hope in the treatment of liver diseases].
Loizeau E
Rev Med Suisse Romande; 1994 Sep; 114(9):755-8. PubMed ID: 7939105
[No Abstract] [Full Text] [Related]
68. Medical therapy for primary sclerosing cholangitis.
Wong GL; Wong VW
Aliment Pharmacol Ther; 2011 Nov; 34(9):1135-6; discussion 1136-7. PubMed ID: 21981734
[No Abstract] [Full Text] [Related]
69. Primary sclerosing cholangitis: Ursodeoxycholic acid derivative: safe and effective.
Dickson I
Nat Rev Gastroenterol Hepatol; 2017 Jul; 14(7):386. PubMed ID: 28611476
[No Abstract] [Full Text] [Related]
70. [Choleretic effects of taurine on experimentally-induced intrahepatic cholestasis].
Sakagami C; Kioka K; Mizoguchi Y; Kida T; Hasegawa I; Ichikawa Y; Tsutsui H; Kobayashi K; Morisawa S
Nihon Shokakibyo Gakkai Zasshi; 1992 Apr; 89(4):1179-84. PubMed ID: 1593775
[TBL] [Abstract][Full Text] [Related]
71. [The EGFR ligand amphiregulin protects from cholestatic liver injury].
Sidibé N; Jalabert H; Merlen G; Tordjmann T
Med Sci (Paris); 2021 Jan; 37(1):103-105. PubMed ID: 33492227
[No Abstract] [Full Text] [Related]
72. Progress and novel discoveries in biliary tract diseases.
Vleggaar FP; van Berge-Henegouwen GP
Eur J Gastroenterol Hepatol; 1999 Jan; 11(1):47-50. PubMed ID: 10495172
[No Abstract] [Full Text] [Related]
73. [Role of ursodeoxycholic acid in pediatric cholestatic disease].
El-Rifai N; Gottrand F
Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 1):852-9. PubMed ID: 15523220
[No Abstract] [Full Text] [Related]
74. [Effect of TUDCA for cholestatic reaction due to serum in patient with primary biliary cirrhosis].
Kuroda H; Satoh N; Tajima J; Sakakibara H; Nakazawa M; Hirose M
Nihon Shokakibyo Gakkai Zasshi; 1993 Feb; 90(2):190. PubMed ID: 8464176
[No Abstract] [Full Text] [Related]
75. Chronic cholestatic liver disease and pregnancy - not to be confused with intrahepatic cholestasis of pregnancy.
Ajne G
BJOG; 2020 Jun; 127(7):885. PubMed ID: 32077233
[No Abstract] [Full Text] [Related]
76. Evidence for a direct hepatoprotective action of ursodeoxycholic acid in primary human hepatocytes.
Borum M; Fromm H
Gastroenterology; 1991 Jul; 101(1):267-8. PubMed ID: 2044917
[No Abstract] [Full Text] [Related]
77. Noninfectious jaundice. Figuring out what's going on.
Celifarco A; Burakoff R
Postgrad Med; 1988 Oct; 84(5):191-3, 196-203. PubMed ID: 3050929
[No Abstract] [Full Text] [Related]
78. Learning from the pregnane X receptor: how to fight one aggressor with two strategies.
Rust C; Beuers U
Liver Int; 2010 Feb; 30(2):161-3. PubMed ID: 20456034
[No Abstract] [Full Text] [Related]
79. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
80. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
